| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 2.998 | 8.119 | 4.848 | 12.023 | 16.050 | 34.343 | 105.101 |
| Total Income - EUR | - | - | - | 2.998 | 8.123 | 6.850 | 13.515 | 16.052 | 36.530 | 105.105 |
| Total Expenses - EUR | - | - | - | 2.819 | 5.726 | 4.215 | 12.273 | 15.528 | 35.924 | 97.767 |
| Gross Profit/Loss - EUR | - | - | - | 179 | 2.397 | 2.635 | 1.242 | 524 | 605 | 7.338 |
| Net Profit/Loss - EUR | - | - | - | 89 | 2.153 | 2.490 | 881 | 124 | 509 | 5.555 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Coşul Sănătăţii Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 845 | 7.297 | 19.196 | 42.003 | 45.452 |
| Current Assets | - | - | - | 1.471 | 4.728 | 10.250 | 2.220 | 2.476 | 6.635 | 12.408 |
| Inventories | - | - | - | 329 | 1.626 | 1.880 | 1.837 | 2.232 | 2.164 | 4.106 |
| Receivables | - | - | - | 271 | 443 | 3.899 | 148 | 161 | 118 | 150 |
| Cash | - | - | - | 871 | 2.660 | 4.472 | 236 | 84 | 4.353 | 8.152 |
| Shareholders Funds | - | - | - | 132 | 2.282 | 4.729 | 5.505 | 5.646 | 6.157 | 11.677 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.339 | 2.446 | 6.367 | 4.012 | 16.026 | 42.480 | 46.220 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4634 - 4634" | |||||||||
| CAEN Financial Year |
4634
|
|||||||||
Comments - Coşul Sănătăţii Bio S.r.l.